The Division of Hematologic Malignancies in the Department of Medicine at Memorial Sloan Kettering Cancer Center is seeking to recruit an exceptional academic physician and leader to serve as Chief of the Myeloma Service. The Division of Hematologic Malignancies is made up of 90 physicians in five services, including: Lymphoma, Leukemia, Myeloma, Benign Hematology and Adult Bone Marrow Transplantation. The Myeloma Service is comprised of 8 physicians, involved in clinical care as well as clinical and laboratory-based research.
The new service chief will report to the Head, Division of Hematologic Malignancies, and will have programmatic oversight and responsibility for the service and faculty. The service chief will work to shape the strategic and programmatic priorities for the service, clinical excellence, clinical operational efficiency, talent acquisition and retention, research, grant funding, professional development, mentorship and teaching. The administrative infrastructure available in the service will allow the service chief to maintain both a clinical practice and an independent research program.
At a minimum, qualified candidates should be/should have an: Nationally recognized clinician as well as a leader in clinical, translational, laboratory based or population science Extensive knowledge of the clinical care of patients with Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and related plasma cell disorders. Board-eligible or board-certified in Medical Oncology Eligible for licensure in New York State and New Jersey
Please include CV, leter of interest and names of references in your application. Please contactValentina Salkow at email@example.com or Monchell Johnson at firstname.lastname@example.org with any additional questions.
Internal Number: 2020-44475
About Memorial Sloan Kettering Cancer Center
At Memorial Sloan Kettering (MSK), we’re not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we’re driving excellence and improving outcomes. For the 28th year, MSK has been named a top hospital for cancer by U.S. News & World Report. We are proud to be on Becker’s Healthcare list as one of the 150 Great Places to Work in Healthcare in 2018, as well as one of Glassdoor’s Employees’ Choice Best Place to Work for 2018. We’re treating cancer, one patient at a time. Join us and make a difference every day.